The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD) ...

Fresenius Kabi is asking hospitals to remove certain pumps because of the risk of an alarm that could interrupt treatment.

The FDA said Fresenius Kabi told customers to remove its Ivenix large-volume infusion pumps from use for repair.

The SEC reached a settlement with Becton Dickinson over allegations of misleading investors regarding risks tied to its Alaris infusion pump. The company agreed to a $175 million civil penalty without ...

Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled ...

Manitoulin Health Centre has launched a fundraising campaign to acquire advanced smart infusion pumps, medical devices ...

Becton, Dickinson settles with SEC for $175M over misleading investors on software flaws in Alaris pumps. Read more here.

BD (NYSE: BDX) announced that it reached an agreement with the SEC to resolve an investigation related to its Alaris system.

Current health news includes scrutiny over Novo's Ozempic drug and its potential link to an eye disease, a campaign against ...